🧠 Could the brain reveal vision loss more accurately than traditional eye tests?

🔗 Using Steady-State Visual Evoked Potentials to Characterize Wide-Ranging Retinopathy Linked to CRB1: Implications for Clinical Trials. Computational and Structural Biotechnology Journal (CSBJ). DOI: https://doi.org/10.34133/csbj.0042

📚 CSBJ - A Science Partner Journal: https://spj.science.org/journal/csbj

#Neuroscience #Ophthalmology #RetinalDiseases #GeneTherapy #EEG #BrainResearch #DigitalHealth #PrecisionMedicine #Neuroimaging

This story is spreading because it shows how close we are to curing diseases at their root.
#GeneTherapy #Healthcare #Science #MedicalInnovation #GlobalHealth #Biotech

👂🧬 The #FDA approved #Otarmeni, the first gene therapy designed to restore #hearing in individuals with a rare form of genetic #deafness caused by OTOF gene mutations.

The one-time treatment delivers a functional copy of the gene into the inner ear, enabling cells to transmit #sound signals to the #brain.

👉 https://www.livescience.com/health/genetics/a-landmark-moment-for-the-field-fda-approves-first-ever-gene-therapy-for-inherited-deafness

#genetics #health #science #biology #medicine #biotechnology #research #genetherapy #innovation

'A landmark moment for the field': FDA approves first-ever gene therapy for inherited deafness

A gene therapy made by Regeneron is the first treatment of its kind approved for genetic hearing loss.

Live Science
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program

The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy.

U.S. Food and Drug Administration
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program

The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy.

U.S. Food and Drug Administration

Gene therapy helps restore vision in six-year-old girl with rare genetic condition

📰 Original title: Six-year-old girl has sight restored by first-of-a-kind gene therapy

🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅

View full AI summary: https://killbait.com/en/gene-therapy-helps-restore-vision-in-six-year-old-girl-with-rare-genetic-condition/?redirpost=b8d7fd1d-9a98-4bee-861f-2268036cca99

#genetics #genetherapy

Gene therapy helps restore vision in six-year-old girl with rare genetic condition

A six-year-old girl with a rare inherited eye disorder has experienced a significant improvement in her vision after receiving an experimental gene therapy, according to her parents and medical team.

KillBait Archive

Gene therapy helps restore vision in six-year-old girl with rare genetic condition

📰 Original title: Six-year-old girl has sight restored by first-of-a-kind gene therapy

🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅

View full AI summary: https://killbait.com/en/gene-therapy-helps-restore-vision-in-six-year-old-girl-with-rare-genetic-condition/?redirpost=b8d7fd1d-9a98-4bee-861f-2268036cca99

#genetics #genetherapy

Gene therapy helps restore vision in six-year-old girl with rare genetic condition

A six-year-old girl with a rare inherited eye disorder has experienced a significant improvement in her vision after receiving an experimental gene therapy, according to her parents and medical team.

KillBait Archive
Annika Kim Constantino reports: A historic agreement slashes drug prices! Regeneron will offer its FDA-approved hearing-loss gene therapy, Otarmeni, free to eligible U.S. patients. This move, made with President Trump, is a significant step for families needing alternatives to cochlear implants. Learn more about this monumental healthcare development.
https://www.cnbc.com/2026/04/23/regeneron-inks-drug-pricing-deal-with-trump-will-offer-hearing-loss-therapy-for-free.html #DrugPricing #Healthcare #GeneTherapy

Six-Year-Old's Vision Altered by Gene Intervention

Six-year-old Saffie Sandford from Stevenage sees better after Luxturna gene therapy for Leber's Congenital Amaurosis at Great Ormond Street Hospital.

#GeneTherapy, #Luxturna, #LCA, #Stevenage, #EyeHealth

https://newsletter.tf/stevenage-girl-vision-gene-therapy-luxturna-lca/

A six-year-old girl's vision has improved significantly after a one-off gene therapy treatment. This is the first time this therapy has been used on such a young child for this condition.

#GeneTherapy, #Luxturna, #LCA, #Stevenage, #EyeHealth
https://newsletter.tf/stevenage-girl-vision-gene-therapy-luxturna-lca/

Stevenage Girl's Sight Improves After Gene Therapy for Rare Eye Condition

Six-year-old Saffie Sandford from Stevenage sees better after Luxturna gene therapy for Leber's Congenital Amaurosis at Great Ormond Street Hospital.

NewsletterTF